All data are based on the daily closing price as of November 20, 2026
s

SD BioSensor

137310.KO
5.52 USD
-0.01
-0.18%

Overview

Last close
5.52 usd
Market cap
666.12M usd
52 week high
8.80 usd
52 week low
3.94 usd
Target price
6.69 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
1.205
Price/Book Value
0.4085
Enterprise Value
536.49M usd
EV/Revenue
0.9462
EV/EBITDA
0.1441

Key financials

Revenue TTM
548.83M usd
Gross Profit TTM
253.33M usd
EBITDA TTM
44.52M usd
Earnings per Share
-4.49 usd
Dividend
0.15 usd
Total assets
1.81B usd
Net debt
N/A usd

About

SD Biosensor, Inc., together with its subsidiaries, operates as an in-vitro diagnostic company in South Korea, India, Asia, Europe, the Americas, and Africa. The company offers STANDARD Q, which provides rapid diagnostic products; STANDARD F, a fluorescence immunodiagnostic system for various qualitative and quantitative diagnosis items; STANDARD E, an enzyme immunoassay diagnosis for large-volume tests; and STANDARD M, a field molecular diagnosis system for infectious disease diagnosis, drug resistance, and genetic testing. It also provides STANDARD i, an analyzer based on chemiluminescence immunoassay technology for detection of clinical biomarkers, including hormones, tumor markers, and infectious diseases; blood glucose meter products; and other products, such as transport medium, d-BLOCK incubator, G6PD analyzer, LipidoCare analyzer, MultiCare analyzer, and Pilot COVID-19 at-home test. The company exports its products. SD Biosensor, Inc. was founded in 1999 and is headquartered in Suwon-si, South Korea.
  • Symbol
    137310.KO
  • Exchange
    KO
  • Isin
    KR7137310009
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Hyo Keun Lee
  • Headquarter
    Suwon-si
  • Web site
    https://www.sdbiosensor.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top